Preventive strategies for COVID-19 in solid organ transplantation recipients
10.3760/cma.j.cn421203-20230225-00041
- VernacularTitle:实体器官移植受者新型冠状病毒感染的预防
- Author:
Chunrong JU
1
;
Jianxing HE
;
Nanshan ZHONG
Author Information
1. 广州医科大学附属第一医院广州呼吸健康研究院，国家呼吸医学中心、国家呼吸疾病临床研究中心、呼吸疾病国家重点实验室，广州 510120
- Keywords:
Organ transplantation;
Recipient;
SARS-CoV-2;
Vaccine;
Neutralizing antibody
- From:
Chinese Journal of Organ Transplantation
2023;44(4):197-202
- CountryChina
- Language:Chinese
-
Abstract:
Since an outbreak of coronavirus disease 2019, there have been more than 664 million confirmed cases and more than 6.7 million deaths worldwide.The Omicron variant discovered in November 2021 has become a dominant variant in China.Compared with the general population, Omicron infection mainly presents short-term upper respiratory symptoms followed by quick recovery; solid organ transplant recipients have the characteristics of a high incidence of severe disease and high mortality after infection, and the incidence of secondary infection and rebound positivity is significantly higher than that of the general population.This review focused upon preventive strategies of solid organ transplant recipients from the perspectives of the characteristics of organ transplant recipients, general preventive strategies, vaccination and long-acting neutralizing antibodies.
